Avestin

What Avestin does

Avestin, Inc. is a privately-held Canadian manufacturer of precision high-pressure homogenization equipment, headquartered in Ottawa, Ontario with a wholly-owned European subsidiary (Avestin Europe GmbH) in Mannheim, Germany. The company designs and sells the EmulsiFlex series of high-pressure homogenizers — bench-top (C3, C5, D20), mid-scale (C50, C55, C160), and production-scale (C500, C1000) systems — capable of operating at pressures up to 30,000 psi (207 MPa). The product portfolio also includes LiposoFast-Basic and Stabilizer liposome extrusion systems, automatic pressure control units, an Aseptic Homogenizer with 6 Zones, and sanitary double-tubesheet heat exchangers. The technology serves particle size reduction (10-100 micron starting material down to uniform 1 micron), nanoscale liposome preparation (demonstrated 89.9 nm in two passes), pharmaceutical emulsion processing (52 nm droplet size), and cell disruption (99.99% non-viable cells at 28,000 psi).

Avestin's business model is built on direct enterprise equipment sales (one-time capital purchase) complemented by professional services — installation, on-site technical support, operator training, warranty service (12 months or 500 hours), and post-warranty repair. Pricing is quote-based and not publicly disclosed; international customers transact in Euros through the German entity under 30-day net terms. The company describes itself as almost 100% export-focused. Go-to-market is enterprise field sales with on-site demonstrations, supported by a website with structured inquiry pathways (information requests, demonstration requests, callbacks).

The customer base spans three primary verticals: pharmaceuticals (named customers include Pfizer, Johnson & Johnson, AstraZeneca, Roche, Merck, Novartis, GSK, Bayer, Gilead, Boehringer Ingelheim, Baxter Healthcare, and Alkermes), research institutions (Memorial Sloan Kettering, Salk Institute, Scripps Research Institute, Max Planck Institute, Korea Institute of Bioscience and Biotechnology), universities (ETH Zurich, Philipps University Marburg, University of Montpellier), and industrial processors (China National Petroleum Corporation, JBF Industrial). Headcount is reported at 1-10 employees and the company is privately held with no disclosed parent, investors, funding rounds, mergers, acquisitions, partnerships, patents, or public awards.

Name

Avestin

Legal name

Avestin, Inc.

Website

https://avestin.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Avestin manufactures precision high-pressure homogenizers (EmulsiFlex series, up to 30,000 psi) and liposome extrusion systems for pharmaceutical drug formulation, biotech research, and industrial processing. The Ottawa-based company sells direct to major pharmaceutical manufacturers and research institutions globally via a wholly-owned European subsidiary in Mannheim, Germany.

Ownership category

akta.pro rank

Product category

High-Pressure Homogenization Equipment

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

akta.pro primary industry

Encapsulation & Emulsified Delivery Systems (Spray-dried emulsions, Lipid microencapsulation) (AFAJACAL)

Keywords

• High-pressure homogenizers
• Liposome extrusion systems
• Pharmaceutical processing equipment
• Particle size reduction
• Cell disruption equipment

Headquarters

HQ city

Ottawa

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Equipment Sales: Sale of high-pressure homogenizers and liposome extrusion systems including EmulsiFlex series, LiposoFast products, and accessory equipment. Sales are primarily direct to pharmaceutical companies, research institutions, and industrial manufacturers. Products include bench-top units (C3, C5, D20) to production-scale systems (C500, C1000).
2. Professional Services and Technical Support: On-site technical support, equipment demonstrations, installation services, and repair services. The company provides training for operators and ongoing technical assistance, including both warranty-covered repairs and chargeable post-warranty service.
3. Warranty and Extended Service: 12-month or 500-hour warranty coverage on equipment, with options for repair services outside warranty period.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Avestin designs, manufactures, and sells precision high-pressure homogenizers and liposome extrusion systems under the EmulsiFlex product line. The equipment is used by pharmaceutical, biotechnology, research, and industrial customers for particle size reduction, emulsion processing, liposome preparation for drug delivery, and cell rupture applications, spanning bench-top to production-scale capacities.

Product overview

Avestin is a manufacturer of precision high-pressure homogenizers and liposome extrusion systems. The product portfolio centers on the EmulsiFlex series of homogenizers (including C3, C5, C50, C55, C160, D20, C500, and C1000 models) which process dispersions, emulsions, liposomes, and enable cell rupture applications. Supporting equipment includes LiposoFast liposome extrusion systems, automatic pressure control units, aseptic processing configurations, and heat exchangers. The systems are used in pharmaceutical, biotechnology, and industrial applications for particle size reduction and uniform distribution.

Differentiator

Problem solved

Functional benefit

Brands

• EmulsiFlex: High-pressure homogenizer product line for processing dispersions, emulsions, liposomes, and cell rupture applications

Products and services

• EmulsiFlex-C3

Quantifiable outcome

• Particle size reduction to uniform 1 micron particles from starting range of 10-100 microns
• +5 more outcomes

Named customers22 records

Segments3 records

Ideal customer profiles3 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• SPX Flow (APV Homogenizers): SPX Flow's APV Homogenizer division is a major incumbent in industrial and pharmaceutical high-pressure homogenization, with a much broader product portfolio and global service network. Avestin competes for the same pharma/biotech applications with its EmulsiFlex line.
• Sonicators / Branson Ultrasonics (Emerson): Branson Ultrasonics (Emerson) offers ultrasonic processors for cell disruption, emulsions, and particle size reduction. They serve as an alternative technology to Avestin's high-pressure homogenization in laboratory and research applications.
• GEA Engineering (formerly Niro) Homogenizers: Part of GEA's broader homogenizer portfolio, these systems target pharmaceutical and biotech applications overlapping with Avestin's EmulsiFlex customer base.
• GEA Niro Soavi: GEA Niro Soavi is a global supplier of high-pressure homogenizers used in pharmaceutical, dairy, and chemical processing. Avestin's EmulsiFlex competes in the pharma/biotech overlap with GEA's homogenizer line.

Emerging players

• Hielscher Ultrasonics: Hielscher manufactures ultrasonic homogenizers and processors for cell disruption, emulsions, and particle size reduction in pharmaceutical and biotech - an alternative technology that competes with Avestin's high-pressure approach.

Direct peers

• Constant Systems (now part of BCH): Constant Systems manufactures high-pressure homogenizers specifically for cell disruption and sample preparation in biotech, pharma, and research - directly competing with Avestin's cell rupture applications using EmulsiFlex.
• BEE International: BEE International produces high-pressure homogenization technologies (Nano DeBEE) for pharmaceutical, biotech, and nanotechnology applications including liposomes and nano-emulsions - a direct peer to Avestin's EmulsiFlex line.
• Bertoli (Pavan Group): Bertoli manufactures high-pressure homogenizers for food, dairy, pharmaceutical, and chemical industries, directly competing with Avestin in pharmaceutical and biotech applications.
• PhD Technology (formerly Microfluidics successor): PhD Technology is an emerging manufacturer of high-pressure homogenization and processing equipment for pharmaceutical and biotech applications, directly competing with Avestin's EmulsiFlex product line.
• Microfluidics International Corporation (Microfluidizer): Microfluidics is the most direct competitor, also manufacturing high-pressure homogenization equipment (Microfluidizer processors) for pharmaceutical, biotech, and research applications. Their processors are used for liposomes, emulsions, and cell disruption - the same applications as Avestin's EmulsiFlex line.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/182411805137002
• LinkedInlinkedin.com/company/avestin-inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Avestin